Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: A randomized, double-blind placebo-controlled study

Journal of Affective Disorders

Volumn 126, Issue 1-2, 2010, Pages 282-286

  Bot, M ^a   Pouwer, F ^a,b   Assies, J ^c   Jansen, E H J M ^d   Diamant, M ^e   Snoek, F J ^b   Beekman, A T F ^b   De Jonge, P ^a,f  

^a TILBURG UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e Diabetes Center   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Depressive symptoms; Diabetes mellitus; Eicosapentaenoic acid; Major depressive disorder; Randomized controlled trial

Indexed keywords

5,8,11,14,17 ICOSAPENTAENOIC ACID; HEMOGLOBIN A1C; INSULIN; MEDIUM CHAIN TRIACYLGLYCEROL; PLACEBO; RAPESEED OIL; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADD ON THERAPY; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ERYTHROCYTE MEMBRANE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTERVENTION STUDY; MAJOR DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PRURITUS; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RASH; SAMPLE SIZE; STOMACH PAIN; THERAPY EFFECT; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADJUVANTS, PHARMACEUTIC; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DIABETES COMPLICATIONS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 77956263859     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.04.008     Document Type: Article

References (20)

1. G. Andrews, and L. Peters The psychometric properties of the Composite International Diagnostic Interview Soc. Psychiatry Psychiatr. Epidemiol. 33 1998 80 88
2. K.M. Appleton, P.J. Rogers, and A.R. Ness Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood Am. J. Clin. Nutr. 91 2010 757 770
3. R.M. Carney, K.E. Freedland, E.H. Rubin, R.M. W., S.B. C., and W.S. Harris Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial JAMA 302 2009 1651 1657
4. T. Decsi, E. Szabo, I. Burus, T. Marosvolgyi, A. Kozari, E. Erhardt, and G. Soltesz Low contribution of n-3 polyunsaturated fatty acids to plasma and erythrocyte membrane lipids in diabetic young adults Prostaglandins Leukot. Essent. Fatty Acids 76 2007 159 164
5. L.E. Egede, D. Zheng, and K. Simpson Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes Diab. Care 25 2002 464 470
6. L.E. Egede, P.J. Nietert, and D. Zheng Depression and all-cause and coronary heart disease mortality among adults with and without diabetes Diab. Care 28 2005 1339 1345
7. E.G.T.M. Hartong, and J.G. Goekoop De Montogomery-Asberg beoordelingsschaal voor depressie Tijdschr. Psychiatr. 27 1985 657 668
8. M.L. Hermens, H.J. Ader, H.P. van Hout, B. Terluin, R. van Dyck, and M. de Haan Administering the MADRS by telephone or face-to-face: a validity study Ann. Gen. Psychiatry 5 2006 3
9. S.L. Jeffcoate Diabetes control and complications: the role of glycated haemoglobin, 25 years on Diabet. Med. 21 2004 657 665
10. P.J. Lustman, and R.E. Clouse Treatment of depression in diabetes: impact on mood and medical outcome J. Psychosom. Res. 53 2002 917 924
11. P.J. Lustman, R.J. Anderson, K.E. Freedland, M. de Groot, R.M. Carney, and R.E. Clouse Depression and poor glycemic control: a meta-analytic review of the literature Diab. Care 23 2000 934 942
12. M.J. Muller, A. Szegedi, H. Wetzel, and O. Benkert Moderate and severe depression. Gradations for the Montgomery-Asberg Depression Rating Scale J. Affect. Disord. 60 2000 137 140
13. G. Parker, N.A. Gibson, H. Brotchie, G. Heruc, A.M. Rees, and D. Hadzi-Pavlovic Omega-3 fatty acids and mood disorders Am. J. Psychiatry 163 2006 969 978
14. M. Peet, and D.F. Horrobin A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs Arch. Gen. Psychiatry 59 2002 913 919
15. F. Pouwer, G. Nijpels, A.T. Beekman, J.M. Dekker, R.M. van Dam, R.J. Heine, and F.J. Snoek Fat food for a bad mood. Could we treat and prevent depression in Type 2 diabetes by means of omega-3 polyunsaturated fatty acids? A review of the evidence Diabet. Med. 22 2005 1465 1475
16. J. Sarris, N. Schoendorfer, and D.J. Kavanagh Major depressive disorder and nutritional medicine: a review of monotherapies and adjuvant treatments Nutr. Rev. 67 2009 125 131
17. M.T. Schram, C.A. Baan, and F. Pouwer Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium Curr. Diab. Rev. 5 2009 112 119
18. J. Sontrop, and M.K. Campbell Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique Prev. Med. 42 2006 4 13
19. J.P. Stevens Repeated measures analysis J.P. Stevens, Applied Multivariate Statistics for the Social Sciences 2002 Lawrence Erlbaum Associates New Jersey 492 557
20. B. Vessby Dietary fat and insulin action in humans Br. J. Nutr. 83 Suppl 1 2000 S91 S96